{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:30:10Z","timestamp":1784629810767,"version":"3.55.0"},"reference-count":39,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To investigate whether the expression of cytokine, nociception-associated ion channel, and axon guidance genes in patients with skin cell fibromyalgia syndrome (FMS) differs from healthy controls, potentially contributing to pain and small-fiber degeneration in FMS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We prospectively recruited 128 patients and 26 healthy controls. All study participants underwent neurological examination, and a skin punch biopsy was obtained from the lateral calf and thigh. Skin samples were processed to histologically determine intraepidermal nerve fiber density (IENFD) and for primary fibroblast and keratinocyte cell cultures. Gene expression of selected pro- and antiinflammatory cytokines, nociception-associated ion channels, and axon guidance cues was assessed with quantitative real-time PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>In fibroblasts, transforming growth factor\u2013\u00df1 (TGF-\u00df1) gene expression was higher in patients with FMS compared to controls (calf and thigh: p &lt; 0.001). Also, expression was higher in patients than in controls for these variables: hyperpolarization-activated cyclic nucleotide-gated ion channel 2 (calf: p &lt; 0.01), ephrin-A4 (EFNA4; calf: p &lt; 0.05, thigh: p &lt; 0.001), and ephrin receptor-A4 (EPHA4; thigh: p &lt; 0.05). In keratinocytes, interleukin 10 gene expression was higher in patients with FMS than in controls (thigh: p &lt; 0.05). While no intergroup difference was found for nociception-associated ion channels, EFNA4 and EPHA4 (calf: p &lt; 0.01 each) expression was higher in patients with FMS than in controls. Axon guide expression did not correlate with IENFD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In FMS, skin cells may contribute to cutaneous nociception by differentially expressing membrane-bound and soluble pain mediators and axon pathfinders.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.190248","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T16:25:11Z","timestamp":1560615911000},"page":"140-148","source":"Crossref","is-referenced-by-count":24,"title":["Pain-associated Mediators and Axon Pathfinders in Fibromyalgia Skin Cells"],"prefix":"10.3899","volume":"47","author":[{"given":"Dimitar","family":"Evdokimov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Kre\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Dinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurcan","family":"\u00dc\u00e7eyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"key":"2022092307201011000_47.1.140.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt053"},{"key":"2022092307201011000_47.1.140.2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/exd.13411","article-title":"What about physical contacts between epidermal keratinocytes and sensory neurons?","volume":"27","author":"Talagas","year":"2018","journal-title":"Exp Dermatol"},{"key":"2022092307201011000_47.1.140.3","doi-asserted-by":"crossref","first-page":"e31684","DOI":"10.7554\/eLife.31684","article-title":"Keratinocytes mediate innocuous and noxious touch via ATP-P2X4 signaling","volume":"7","author":"Moehring","year":"2018","journal-title":"Elife"},{"key":"2022092307201011000_47.1.140.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2010.04.008"},{"key":"2022092307201011000_47.1.140.5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/exd.12288","article-title":"Coculture system of keratinocytes and dorsal-root-ganglion-derived cells for screening neurotrophic factors involved in guidance of neuronal axon growth in the skin","volume":"23","author":"Kumamoto","year":"2014","journal-title":"Exp Dermatol"},{"key":"2022092307201011000_47.1.140.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.11.012"},{"key":"2022092307201011000_47.1.140.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2011.02.004"},{"key":"2022092307201011000_47.1.140.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01140.x"},{"key":"2022092307201011000_47.1.140.9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1073140"},{"key":"2022092307201011000_47.1.140.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.03.016"},{"key":"2022092307201011000_47.1.140.11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2017.11.025","article-title":"High glucose up-regulates Semaphorin 3A expression via the mTOR signaling pathway in keratinocytes: a potential mechanism and therapeutic target for diabetic small fiber neuropathy","volume":"472","author":"Wu","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"2022092307201011000_47.1.140.12","first-page":"146","article-title":"Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia","volume":"30","author":"Salemi","year":"2003","journal-title":"J Rheumatol"},{"key":"2022092307201011000_47.1.140.13","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-014-0185-0"},{"key":"2022092307201011000_47.1.140.14","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000668"},{"key":"2022092307201011000_47.1.140.15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00482-017-0200-7","article-title":"[Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles]","volume":"31","author":"Eich","year":"2017","journal-title":"Schmerz"},{"key":"2022092307201011000_47.1.140.16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20140"},{"key":"2022092307201011000_47.1.140.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330203"},{"key":"2022092307201011000_47.1.140.18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.25565","article-title":"Reduction of skin innervation is associated with a severe fibromyalgia phenotype","volume":"86","author":"Evdokimov","year":"2019","journal-title":"Ann Neurol"},{"key":"2022092307201011000_47.1.140.19","first-page":"1984","article-title":"Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G)","volume":"27","author":"Offenb\u00e4cher","year":"2000","journal-title":"J Rheumatol"},{"key":"2022092307201011000_47.1.140.20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e0f7b3"},{"key":"2022092307201011000_47.1.140.21","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1999.4085"},{"key":"2022092307201011000_47.1.140.22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-245"},{"key":"2022092307201011000_47.1.140.23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","article-title":"Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study","volume":"84","author":"Ranzolin","year":"2016","journal-title":"Cytokine"},{"key":"2022092307201011000_47.1.140.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.02.002"},{"key":"2022092307201011000_47.1.140.25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JPR.S128508","article-title":"Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma","volume":"10","author":"Backryd","year":"2017","journal-title":"J Pain Res"},{"key":"2022092307201011000_47.1.140.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1474-7"},{"key":"2022092307201011000_47.1.140.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.22026"},{"key":"2022092307201011000_47.1.140.28","doi-asserted-by":"crossref","first-page":"e28205","DOI":"10.1371\/journal.pone.0028205","article-title":"IL-4 deficiency is associated with mechanical hypersensitivity in mice","volume":"6","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"PLoS One"},{"key":"2022092307201011000_47.1.140.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.06.011"},{"key":"2022092307201011000_47.1.140.30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1523-1747.2002.19504.x","article-title":"gamma-Aminobutyric acid (A) receptor agonists accelerate cutaneous barrier recovery and prevent epidermal hyperplasia induced by barrier disruption","volume":"119","author":"Denda","year":"2002","journal-title":"J Invest Dermatol"},{"key":"2022092307201011000_47.1.140.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.08.025"},{"key":"2022092307201011000_47.1.140.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2006.00418.x"},{"key":"2022092307201011000_47.1.140.33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1113\/jphysiol.1991.sp018568","article-title":"Characterization of ion channels seen in subconfluent human dermal fibroblasts","volume":"436","author":"Estacion","year":"1991","journal-title":"J Physiol"},{"key":"2022092307201011000_47.1.140.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2006.00529.x"},{"key":"2022092307201011000_47.1.140.35","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0807-7"},{"key":"2022092307201011000_47.1.140.36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001867"},{"key":"2022092307201011000_47.1.140.37","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1662"},{"key":"2022092307201011000_47.1.140.38","doi-asserted-by":"publisher","DOI":"10.4161\/cam.4.3.11586"},{"key":"2022092307201011000_47.1.140.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.01.020"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:26:50Z","timestamp":1663943210000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,1]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.3899\/jrheum.190248"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190248","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]}}}